Full Text Journal Articles in
Journal Kidney Int

Advertisement

Find full text journal articles






On the need to better protect hemodialysis patients. A comment on "IMPact of the COVID-19 epidemic on the moRTAlity of kidney transplant recipients and candidates in a French Nationwide registry sTudy (IMPORTANT)".

Torreggiani Massimo, Fessi Hafedh, Piccoli Giorgina Barbara,

Kidney Int (Kidney international)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Management of acute kidney injury in symptomatic multiple myeloma.

Frank Bridoux, Nelson Leung, Mohamed Belmouaz, Virginie Royal, Pierre Ronco, Samih H Nasr, Jean Paul Fermand, ,

Symptomatic multiple myeloma (MM) is commonly complicated by acute kidney injury (AKI), through various mechanisms. The most frequent is the precipitation of monoclonal free light chains (FLC) with uromodulin in the distal tubules, defining light chain cast nephropathy (LCCN). Early diagnosis and identification of the cause of AKI are required ... Read more >>

Kidney Int (Kidney international)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Advertisement

Response to "On the need to better protect hemodialysis patients. A comment on the IMPORTANT study": one more IMPORTANT thing!

Olivier Thaunat, Camille Legeai, Olivier Bastien, Sophie Caillard,

Kidney Int (Kidney international)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Non-oxidized parathyroid hormone (PTH) measured by current method is not superior to total PTH in assessing bone turnover in chronic kidney disease.

Stan R Ursem, Annemieke C Heijboer, Patrick C D'Haese, Geert J Behets, Etienne Cavalier, Marc G Vervloet, Pieter Evenepoel,

Parathyroid hormone (PTH) is a key regulator of bone turnover but can be oxidized in vivo, which impairs biological activity. Variable PTH oxidation may account for the rather poor correlation of PTH with indices of bone turnover in chronic kidney disease. Here, we tested whether non-oxidized PTH is superior to ... Read more >>

Kidney Int (Kidney international)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Differential expression of microRNA miR-150-5p in IgA nephropathy as a potential mediator and marker of disease progression.

Izabella Za Pawluczyk, Athanasios Didangelos, Sean J Barbour, Lee Er, Jan U Becker, Roberto Martin, Scott Taylor, Jasraj S Bhachu, Edward G Lyons, Robert Jenkins, Donald Fraser, Karen Molyneux, Javier Perales-Patón, Julio Saez-Rodriguez, Jonathan Barratt,

Understanding why certain patients with IgA nephropathy progress to kidney failure while others maintain normal kidney function remains a major unanswered question. To help answer this, we performed miRnome profiling by next generation sequencing of kidney biopsies in order to identify microRNAs specifically associated with the risk of IgA nephropathy ... Read more >>

Kidney Int (Kidney international)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Chlorthalidone with potassium citrate decreases calcium oxalate stones and increases bone quality in genetic hypercalciuric stone-forming rats.

Nancy S Krieger, John Asplin, Ignacio Granja, Luojing Chen, Daiana Spataru, Tong Tong Wu, Marc Grynpas, David A Bushinsky,

To study human idiopathic hypercalciuria we developed an animal model, genetic hypercalciuric stone-forming rats, whose pathophysiology parallels that of human idiopathic hypercalciuria. Fed the oxalate precursor, hydroxyproline, every rat in this model develops calcium oxalate stones. Using this rat model, we tested whether chlorthalidone and potassium citrate combined would reduce ... Read more >>

Kidney Int (Kidney international)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Rho-GTPase Activating Protein myosin MYO9A identified as a novel candidate gene for monogenic focal segmental glomerulosclerosis.

Qi Li, Ashima Gulati, Mathieu Lemaire, Timothy Nottoli, Allen Bale, Alda Tufro,

Focal segmental glomerulosclerosis (FSGS) is a podocytopathy leading to kidney failure, whose molecular cause frequently remains unresolved. Here, we describe a rare MYO9A loss of function nonsense heterozygous mutation (p.Arg701*) as a possible contributor to disease in a sibling pair with familial FSGS/proteinuria. MYO9A variants of uncertain significance were identified ... Read more >>

Kidney Int (Kidney international)
[2021, :]

Cited: 0 times

View full text PDF listing >>



SEX MATTERS - COVID-19 IN KIDNEY TRANSPLANTATION.

Amanda J Vinson, Anita S Chong, Deborah Clegg, Christine Falk, Bethany J Foster, Anne Halpin, Roslyn B Mannon, Biff F Palmer, Sabine Oertelt-Prigione, Lori J West, Germaine Wong, Ruth Sapir-Pichhadze,

Kidney Int (Kidney international)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Does gouty nephropathy exist, and is it more common than we think?

Federica Piani, Richard J Johnson,

Gout is present in one third of subjects with CKD but is usually an exclusion criterion in clinical trials investigating the role of uric acid in kidney disease. Bardin et al. report that one third of gouty subjects have hyperechoic medullas by ultrasound (consistent with crystalline deposits) that correlates with increased ... Read more >>

Kidney Int (Kidney international)
[2021, 99(1):31-33]

Cited: 0 times

View full text PDF listing >>



The mystery of cherry red ultrafiltrate in continuous renal replacement therapy.

Naveen Bade, Dana V Rizk,

Kidney Int (Kidney international)
[2021, 99(1):270]

Cited: 0 times

View full text PDF listing >>



Nrf2 activation for kidney disease treatment-a mixed blessing?

Masahiro Nezu, Norio Suzuki,

Activation of cellular antioxidative signaling is expected to be a silver bullet against kidney diseases, and clinical trials of compounds activating the antioxidant transcription factor Nrf2 have revealed their renoprotective effects. However, cardiac events have been observed in some cases with elevated urinary albumin excretion in these trials. Therefore, elucidating ... Read more >>

Kidney Int (Kidney international)
[2021, 99(1):20-22]

Cited: 0 times

View full text PDF listing >>



The Case | A lockdown-related metabolic acidosis.

Cyril Mousseaux, Chloë Schwarz, Hugo Garcia, Inna Mohamadou, Laurent Mesnard, Yosu Luque,

Kidney Int (Kidney international)
[2021, 99(1):273-274]

Cited: 0 times

View full text PDF listing >>



Predicting long-term kidney allograft outcomes: pitfalls and progress.

Alex Dinh, Charles E McCulloch, Elaine Ku,

Early identification of kidney transplant recipients at risk of progressive allograft dysfunction may allow clinicians to provide closer monitoring and more aggressive risk factor modification. In this issue, Raynaud et al. presented a latent class model that clustered kidney transplant recipients into 8 risk categories of post-transplant kidney function loss. This ... Read more >>

Kidney Int (Kidney international)
[2021, 99(1):24-26]

Cited: 0 times

View full text PDF listing >>



Hyperuricemia and progression of chronic kidney disease: to treat or not to treat?

Jürgen Floege, Richard J Johnson,

Kidney Int (Kidney international)
[2021, 99(1):14-16]

Cited: 0 times

View full text PDF listing >>



Reinnovating nephrology-a call to action.

Ishita Moghe, Rebecca Hu, Puja Dhungana, William H Fissell, Kim Solez,

Kidney Int (Kidney international)
[2021, 99(1):5-8]

Cited: 0 times

View full text PDF listing >>



WAGR syndrome.

Yoshinosuke Shimamura, Takayuki Okamoto, Koki Abe, Maeda Takuto, Yayoi Ogawa, Hideki Takizawa,

Kidney Int (Kidney international)
[2021, 99(1):271]

Cited: 0 times

View full text PDF listing >>



Stem cell sheet therapy: another option for acute kidney injury?

Takashi Yokoo,

Recent advances in material engineering and gene editing techniques have now made it possible to use sheeted stem cells as distributors of therapeutic factors in clinical practice (e.g., as beating sheets for patients with heart failure). In this issue, Park et al. report the effects of sheets of genome-engineered human umbilical ... Read more >>

Kidney Int (Kidney international)
[2021, 99(1):22-24]

Cited: 0 times

View full text PDF listing >>



A novel mouse model of hyperuricemia expressing a human functional ABCG2 variant.

Anna Köttgen, Michael Köttgen,

Kidney Int (Kidney international)
[2021, 99(1):12-14]

Cited: 0 times

View full text PDF listing >>



The Case | An unusual cause of tender skin lesion in an end-stage kidney disease patient.

Nattawat Klomjit, Kabeer Shah, Sandra M Herrmann, John C Lieske,

Kidney Int (Kidney international)
[2021, 99(1):275-276]

Cited: 0 times

View full text PDF listing >>



Equitable hemodialysis for undocumented immigrant patients: prioritizing patient voices in care implementation.

Nwamaka D Eneanya,

Undocumented immigrant patients with kidney disease in the United States are rightfully gaining increased access to scheduled hemodialysis treatments. For health care systems that have transitioned from emergency to more consistent treatments, the impact of this care on patients' livelihood remains unknown. Cervantes and colleagues provide evidence to better understand ... Read more >>

Kidney Int (Kidney international)
[2021, 99(1):26-28]

Cited: 0 times

View full text PDF listing >>



Multistain segmentation of renal histology: first steps toward artificial intelligence-augmented digital nephropathology.

Roman D Bülow, Jesper Kers, Peter Boor,

Artificial intelligence (AI), and particularly deep learning (DL), are showing great potential in improving pathology diagnostics in many aspects, 1 of which is the segmentation of histology into (diagnostically) relevant compartments. Although most current studies focus on AI and DL in oncologic pathology, an increasing number of studies explore their ... Read more >>

Kidney Int (Kidney international)
[2021, 99(1):17-19]

Cited: 0 times

View full text PDF listing >>



Innate lymphoid cells in kidney diseases.

Ruifeng Wang, Yiping Wang, David C H Harris, Qi Cao,

It is well known that innate immune cells, including dendritic cells, macrophages and natural killer cells contribute to pathogenesis and protection in various kidney diseases. The understanding of innate immunity has been advanced recently by the discovery of a new group of innate lymphoid cells (ILCs) including ILC1, ILC2, and ... Read more >>

Kidney Int (Kidney international)
[2020, :]

Cited: 0 times

View full text PDF listing >>



Monitoring acid base status in CKD patients: can urinary citrate help?

Caroline Prot-Bertoye, Marion Vallet, Pascal Houillier,

Metabolic acidosis is an early and deleterious complication of chronic kidney disease. Because it is frequently eubicarbonatemic, diagnosis may be difficult. In this issue, Gianella et al. suggest that lower urinary citrate excretion, considered as an homeostatic response to metabolic acidosis, may be helpful for early diagnosis and monitoring of alkali ... Read more >>

Kidney Int (Kidney international)
[2021, 99(1):28-31]

Cited: 0 times

View full text PDF listing >>



Discrepant post-filter ionized calcium concentrations by 2 common gas analyzers in continuous renal replacement therapy using regional citrate anticoagulation: another piece of the puzzle.

Romaric Larcher, Nils Kuster, Anne-Sophie Bargnoux, Kada Klouche, Laurence Pieroni, Jean-Paul Cristol,

Kidney Int (Kidney international)
[2021, 99(1):268-269]

Cited: 0 times

View full text PDF listing >>



Milestones in nephrology and welcoming the future: the 61st anniversary of the International Society of Nephrology.

Pierre Ronco, Brad Rovin, Masaomi Nangaku, Christina Wyatt, Vivek Jha, ,

Kidney Int (Kidney international)
[2021, 99(1):2-4]

Cited: 0 times

View full text PDF listing >>



Advertisement

Disclaimer
1.0768 s